SEC Form 4 · accession 0001420295-17-000002
Alarm.com Holdings, Inc. · ALRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Jay C Hoag
10% Owner · Other
Jon Q Reynolds Jr.
10% Owner · Other
John Drew
10% Owner · Other
Rick Kimball
10% Owner · Other
Robert Trudeau
10% Owner · Other
TCV Member Fund, L.P.
10% Owner · Other
Vii(a) L P Tcv
10% Owner · Other
TCV VII LP
10% Owner · Other
Christopher P Marshall
10% Owner · Other
Technology Crossover Management VII, L.P.
10% Owner · Other
Period of report
Nov 27, 2017
Accepted (ET)
Nov 29, 2017 · 6:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459200
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 7, 2017 | G | 2,248 | $0.00 | D | 18,829 | I | Marshall Carroll 2000 Trust |
| Common StockF4 | Sep 8, 2017 | G | 34,060 | $0.00 | D | 0 | I | Drew Family Trust dated 10/5/2004 |
| Common StockF6 | Nov 27, 2017 | J | 1,308,234 | $0.00 | D | 8,579,694 | I | TCV VII, L.P. |
| Common StockF8 | Nov 27, 2017 | J | 679,396 | $0.00 | D | 4,455,634 | I | TCV VII (A), L.P. |
| Common StockF10 | Nov 27, 2017 | J | 12,370 | $0.00 | D | 81,123 | I | TCV Member Fund, L.P. |
| Common StockF12 | Nov 27, 2017 | J | 504,361 | $0.00 | A | 504,361 | I | Technology Crossover Management VII, L.P. |
| Common StockF12 | Nov 27, 2017 | J | 500,351 | $0.00 | D | 4,010 | I | Technology Crossover Management VII, L.P. |
| Common StockF15 | Nov 27, 2017 | J | 46,763 | $0.00 | A | 93,288 | I | Hoag Family Trust U/A Dtd 8/2/94 |
| Common StockF17 | Nov 27, 2017 | J | 46,763 | $0.00 | A | 93,288 | I | Hamilton Investments Limited Partnership |
| Common StockF19 | Nov 27, 2017 | J | 64,629 | $0.00 | A | 128,931 | I | Goose Rocks Beach Partners, L.P. |
| Common StockF21 | Nov 27, 2017 | J | 57,120 | $0.00 | A | 113,952 | I | Reynolds Family Trust |
| Common StockF4 | Nov 27, 2017 | J | 34,232 | $0.00 | A | 34,232 | I | Drew Family Trust dated 10/5/2004 |
| Common StockF24 | Nov 27, 2017 | J | 20,956 | $0.00 | A | 20,956 | I | Ten 271 Partners B |
| Common StockF26 | Nov 27, 2017 | J | 55,187 | $0.00 | A | 55,187 | I | Robert W. Trudeau |
| Common StockF2 | Nov 27, 2017 | J | 21,185 | $0.00 | A | 40,014 | I | Marshall Carroll 2000 Trust |
| Common StockF29 | Nov 27, 2017 | J | 266 | $0.00 | A | 532 | I | Marshall Partners |
| Common StockF30,F12 | Nov 28, 2017 | S | 3,943 | $42.4231 | D | 67 | I | Technology Crossover Management VII, L.P. |
| Common StockF12 | Nov 28, 2017 | S | 67 | $42.87 | D | 0 | I | Technology Crossover Management VII, L.P. |
| Common StockF31,F26 | Nov 28, 2017 | S | 55,187 | $43.5068 | D | 0 | I | Robert W. Trudeau |
| Common StockF2 | Nov 28, 2017 | S | 7,234 | $43.50 | D | 32,780 | I | Marshall Carroll 2000 Trust |
| Common StockF29 | Nov 28, 2017 | S | 266 | $43.50 | D | 266 | I | Marshall Partners |
| Common StockF32,F4 | Nov 29, 2017 | S | 29,332 | $41.0466 | D | 4,900 | I | Drew Family Trust dated 10/5/2004 |
| Common StockF33,F4 | Nov 29, 2017 | S | 4,900 | $41.721 | D | 0 | I | Drew Family Trust dated 10/5/2004 |
| Common StockF32,F24 | Nov 29, 2017 | S | 17,952 | $41.0466 | D | 3,004 | I | Ten 271 Partners B |
| Common StockF33,F24 | Nov 29, 2017 | S | 3,004 | $41.721 | D | 0 | I | Ten 271 Partners B |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a gift/charitable donation effective September 7, 2017. Not a market transaction thus no price is reported. No value was received in return for the gifted shares.
- F10These securities are directly held by TCV MF. The TCM VII Directors are Class A Directors of Management VII, which is a General Partner of TCV MF, and Limited Partners of TCV MF. The TCM VII Directors and Management VII may be deemed to beneficially own the securities held by TCV MF, but the TCM VII Directors and Management VII each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- F11Acquisition by TCM VII pursuant to an in kind pro-rata distribution by TCV VII and TCV VII (A) to each of their partners, without consideration.
- F12These securities are directly held by TCM VII. The TCM VII Directors are Class A Directors of Management VII, which is the General Partner of TCM VII and Limited Partners of TCM VII. The TCM VII Directors and Management VII may be deemed to beneficially own the securities held by TCM VII, but the TCM VII Directors and Management VII each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- F13In kind pro-rata distribution by TCM VII to its partners, without consideration.
- F14Acquisition by the Hoag Family Trust U/A Dtd 8/2/94 pursuant to an in kind pro-rata distribution by TCM VII and TCV MF to each of their partners, without consideration.
- F15Jay C. Hoag is the Trustee of the Hoag Family Trust U/A Dtd 8/2/94. Mr. Hoag disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F16Acquisition by the Hamilton Investments Limited Partnership pursuant to an in kind pro-rata distribution by TCM VII and TCV MF to each of their partners, without consideration.
- F17Jay C. Hoag is a General Partner of Hamilton Investments Limited Partnership. Mr. Hoag disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F18Acquisition by Goose Rocks Beach Partners, L.P. pursuant to an in kind pro-rata distribution by TCM VII and TCV MF to each of their partners, without consideration.
- F19Richard H. Kimball is a General Partner of Goose Rocks Beach Partners, L.P. Mr. Kimball disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F2Christopher P. Marshall is a Trustee of the Marshall Carroll 2000 Trust. Mr. Marshall disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F20Acquisition by the Reynolds Family Trust pursuant to an in kind pro-rata distribution by TCM VII and TCV MF to each of their partners, without consideration.
- F21Jon Q. Reynolds is a Trustee of the Reynolds Family Trust. Mr. Reynolds disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F22Acquisition by the Drew Family Trust dated 10/5/2004 pursuant to an in kind pro-rata distribution by TCM VII and TCV MF to each of their partners, without consideration.
- F23Acquisition by Ten 271 Partners B pursuant to an in kind pro-rata distribution by TCM VII and TCV MF to each of their partners, without consideration.
- F24John L. Drew is a General Partner of Ten 271 Partners B. Mr. Drew disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F25Acquisition by Robert W. Trudeau pursuant to an in kind pro-rata distribution by TCM VII and TCV MF to each of their partners, without consideration.
- F26Shares held directly by Robert W. Trudeau.
- F27Acquisition by the Marshall Carroll 2000 Trust pursuant to an in kind pro-rata distribution by TCM VII and TCV MF to each of their partners, without consideration.
- F28Acquisition by Marshall Partners pursuant to an in kind pro-rata distribution by TCV MF to its partners, without consideration.
- F29Christopher P. Marshall is a General Partner of Marshall Partners. Mr. Marshall disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F3Represents a gift/charitable donation effective September 8, 2017. Not a market transaction thus no price is reported. No value was received in return for the gifted shares.
- F30This number represents a weighted average sales price. The shares were sold at prices ranging from $41.865 to $42.86. The Reporting Person hereby undertakes to provide upon request by the Staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- F31This number represents a weighted average sales price. The shares were sold at prices ranging from $43.50 to $43.625. The Reporting Person hereby undertakes to provide upon request by the Staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- F32This number represents a weighted average sales price. The shares were sold at prices ranging from $40.62 to $41.59. The Reporting Person hereby undertakes to provide upon request by the Staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- F33This number represents a weighted average sales price. The shares were sold at prices ranging from $41.59 to $42.10. The Reporting Person hereby undertakes to provide upon request by the Staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- F4John L. Drew is a Trustee of the Drew Family Trust dated 10/5/2004. Mr. Drew disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F5In kind pro-rata distribution by TCV VII, L.P. ("TCV VII") to its partners, without consideration.
- F6These securities are directly held by TCV VII. Timothy P. McAdam, Jay C. Hoag, Christopher P. Marshall, Jon Q. Reynolds, Jr., Richard H. Kimball, John L. Drew, Robert W. Trudeau, John C. Rosenberg and David L. Yuan (collectively, the "TCM VII Directors") are Class A Directors of Technology Crossover Management VII, Ltd. ("Management VII") and Limited Partners of Technology Crossover Management VII, L.P. ("TCM VII"). Management VII is the General Partner of TCM VII, which is the General Partner of TCV VII, L.P. The TCM VII Directors, Management VII and TCM VII may be deemed to beneficially own the securities held by TCV VII, L.P., but each of the TCM VII Directors, Management VII and TCM VII disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- F7In kind pro-rata distribution by TCV VII (A), L.P. ("TCV VII (A)") to its partners, without consideration.
- F8These securities are directly held by TCV VII (A). The TCM VII Directors are Class A Directors of Management VII and Limited Partners of TCM VII. Management VII is the General Partner of TCM VII, which is the General Partner of TCV VII (A). The TCM VII Directors, Management VII and TCM VII may be deemed to beneficially own the securities held by TCV VII (A), but each of the TCM VII Directors, Management VII and TCM VII disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- F9In kind pro-rata distribution by TCV Member Fund, L.P. ("TCV MF") to its partners, without consideration.
Remarks
This Form 4 is filed by more than one Reporting Person and is a joint filing with the Form 4 filed by Timothy P. McAdam, John C. Rosenberg and David L. Yuan on November 29, 2017.